Imported and indigenous cases of invasive meningocococcal disease W:P1.5,2:F1-1: ST-11 in migrants’ reception centers. Italy, June-November 2014

Advances in Experimental Medicine and Biology

Volumn 897, Issue , 2016, Pages 81-83

  Stefanelli, Paola ^a   Fazio, Cecilia ^a   Neri, Arianna ^a   Rezza, Giovanni ^a   Severoni, Santino ^b   Vacca, Paola ^a   Fasciana, Teresa ^c   Bisbano, Alessandro ^d   Di Bernardo, Francesca ^e   Giammanco, Anna ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b European Office for Investment for Health and Development WHO Europe   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Epidemiology Unit ASP Crotone   (Italy)

^e ARNAS Civico General Hospital   (Italy)

Author keywords

Migrant; Neisseria meningitides; Serogroup W; Typing

Indexed keywords

CIPROFLOXACIN; MENINGOCOCCUS VACCINE; RIFAMPICIN;

ADULT; BACTERIAL STRAIN; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHEMOPROPHYLAXIS; FEMALE; HUMAN; INFECTION RISK; ITALY; LUMBAR PUNCTURE; MALE; MENINGOCOCCEMIA; MIGRANT; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RISK REDUCTION; TIME SERIES ANALYSIS; YOUNG ADULT; ADOLESCENT; ERITREA; ISOLATION AND PURIFICATION; MALI; MENINGITIS, MENINGOCOCCAL; MICROBIOLOGY;

ADOLESCENT; ADULT; EMIGRANTS AND IMMIGRANTS; ERITREA; FEMALE; HUMANS; ITALY; MALE; MALI; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS, SEROGROUP W-135;

EID: 84962737913     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2015_5006     Document Type: Chapter

References (12)

1. Guindo I et al (2011) Clones of Neisseria meningitides strains in Mali. Med Mal Infect 41:7–13
2. Jolley KA, Maiden MC (2010) BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinf 11:595
3. Kelly D, Pollard AJ (2003) W135 in Africa: origins, problems and perspectives. Travel Med Infect Dis 1:19–28
4. Kwara A et al (1998) Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health 3:742–746
5. MacLennan JM et al (2000) Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunization policy? Lancet 356:1078
6. Nathan N et al (2007) (2002) Meningitis serogroup W135 outbreak, Burkinia Faso. Emerg Infect Dis 13:920–923
7. Parent du Chatelet I et al (2012) W135 invasive meningococcal infections imported from Sub-Saharan Africa to France. Euro Surveill 17:pii: 20181
8. Puleston R et al (2012) An unusual transmission event of Neisseria meningitidis serogroup W135 type 2a in a healthcare setting, England, 2012. Euro Surveill 17: pii: 20308.
9. Severoni S, Dembech M (2014) Technical briefing for WHO Member States, Copenhagen, RC 64-2014.
10. Stephens DS (1999) Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 353:941–942
11. Wilder-Smith A et al (2003) Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 36:679–683
12. World Health Organization (2013) Meningococcal disease in countries of the African meningitis belt, 2012 – emerging needs and future perspectives. Wkly Epidemiol Rec 88:129–136